These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2771134)

  • 21. Prophylaxis of venous thrombosis after gynaecological surgery: a controlled pilot study of defibrotide.
    Palareti G; Guazzaloca G; Legnani C; Leali N; Busacchi P; Sani G; Levorato M; Di Marco MG; Coccheri S
    Haematologica; 1992; 77(1):44-8. PubMed ID: 1398281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the efficacy of profibrinolytic treatment with defibrotide in the therapy of thrombophlebitis].
    Murgiano GA
    Clin Ter; 1988 Dec; 127(5):355-61. PubMed ID: 2976633
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of deep venous thrombosis with defibrotide. Pilot study].
    Sammarco M; Garofalo M; Nazzari M
    Minerva Med; 1988 Jun; 79(6):495-7. PubMed ID: 2967927
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of defibrotide in the treatment of acute superficial thrombophlebitis of the legs].
    Seccia M; Bortolotti P; Bellomini MG; Buccianti P; Chiarugi M; Cavina E
    Minerva Chir; 1989 May; 44(9):1379-84. PubMed ID: 2761740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Thromboembolic risk].
    Campisi M; Stacca R; Tassi A; Laganà G; Piccinini P
    Minerva Anestesiol; 1988 Oct; 54(10):405-12. PubMed ID: 3255087
    [No Abstract]   [Full Text] [Related]  

  • 26. Defibrotide therapy for thrombophlebitis--controlled clinical trial.
    Di Perri T; Vittoria A; Messa GL; Cappelli R
    Haemostasis; 1986; 16 Suppl 1():42-7. PubMed ID: 3754835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk and prevention of venous thromboembolic complications in surgery].
    Baeshko AA
    Khirurgiia (Mosk); 2001; (4):61-9. PubMed ID: 11490498
    [No Abstract]   [Full Text] [Related]  

  • 29. [Defibrotide vs. calcium heparin in the prevention of deep vein thrombosis in gynecologic oncologic surgery].
    Fontanelli A; Falcini F; Lippi G; Lucente E; Morelli P; Viliani T; Nuzzaci G; Massi GB
    Minerva Ginecol; 1992 May; 44(5):251-5. PubMed ID: 1608523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The prevention of deep venous thromboses after radical or modified mastectomy interventions].
    Interdonato F; Festi L; Gerosa C; Benevento A; Dionigi R
    Minerva Chir; 1990 Nov; 45(21-22):1389-92. PubMed ID: 2097565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
    Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
    Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of thromboembolism in gynecologic surgery].
    Rajić S; Marković A
    Srp Arh Celok Lek; 1979 May; 107(5):483-6. PubMed ID: 538528
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of thromboembolic disease in gynecologic surgery].
    Lugonja V; Marković A; Runić S; Jeremić M; Grubor D; Vujinović N
    Med Pregl; 1995; 48(1-2):30-1. PubMed ID: 8657053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
    Eriksson BI; Bauer KA; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1298-304. PubMed ID: 11794148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgeon practices regarding postoperative thromboembolic prophylaxis after high-risk spinal surgery.
    Glotzbecker MP; Bono CM; Harris MB; Brick G; Heary RF; Wood KB
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2915-21. PubMed ID: 19092624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
    Bauer KA; Eriksson BI; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1305-10. PubMed ID: 11794149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective study on the use of a low-molecular-weight heparin for thromboembolism prophylaxis in large-volume liposuction and body contouring procedures.
    Newall G; Ruiz-Razura A; Mentz HA; Patronella CK; Ibarra FR; Zarak A
    Aesthetic Plast Surg; 2006; 30(1):86-95; discussion 96-7. PubMed ID: 16404651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defibrotide: properties and clinical use of an old/new drug.
    Pescador R; Capuzzi L; Mantovani M; Fulgenzi A; Ferrero ME
    Vascul Pharmacol; 2013; 59(1-2):1-10. PubMed ID: 23680861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of defibrotide in the treatment of arterial and venous vascular disease. A preliminary report.
    Belcaro G; Legnini M; Cianchetti E; Errichi BM; Laurora G; Cipollone G; Leone L; Melena E; Lania M; Gaspari AL
    Panminerva Med; 1989; 31(1):34-41. PubMed ID: 2657592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.